CARLOS MANUEL
PANIZO SANTOS
Universidad de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Salamanca (9)
2023
-
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
Journal for immunotherapy of cancer, Vol. 11, Núm. 2
2022
-
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
Science Advances, Vol. 8, Núm. 3
2019
-
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Blood, Vol. 133, Núm. 22, pp. 2401-2412
2018
-
Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73
2016
2010
-
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era
European Journal of Haematology, Vol. 85, Núm. 4, pp. 321-328
2009
-
Identification of leptomeningeal disease in aggressive B-Cell non-Hodgkin's lymphoma: Improved sensitivity of flow cytometry
Journal of Clinical Oncology, Vol. 27, Núm. 9, pp. 1462-1469
-
Prolonged idiotypic vaccination against follicular lymphoma
Leukemia and Lymphoma, Vol. 50, Núm. 1, pp. 47-53
2006
-
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
Journal of the National Cancer Institute, Vol. 98, Núm. 18, pp. 1292-1301